Nucleate Germany is partnering with hei_INNOVATION, the tech transfer office of Uni Heidelberg , to drive growth and development through cutting-edge biotech innovations. Our partnership is a step towards making Germany a leading biotech hub.

Check out the latest episode of the Nucleate Podcast featuring Jake Becraft, co-founder and CEO of Strand Therapeutics, who shares his journey from MIT to building a clinical-stage biotech company revolutionizing mRNA therapeutics. nucleate-signal.ghost.io/ghost/#/editor…

👥 Founder Focus: Building a Biotech Ecosystem with Nucleate Germany We’re hosting a workshop at SynBioReactor, organized by GASB SynBio, to explore biotech entrepreneurship & the Nucleate Activator Program! 🚀 Join us & share your insights - let’s build together! Nucleate

🚀 Kicking off 2025 with an incredible Nucleate Germany event in Munich! A huge thank you to the scientists, entrepreneurs & innovators who joined. 🗓️ Stay tuned for more events - let’s shape the future, together! Nucleate

What if machine learning could revolutionize gene therapy? That’s exactly what Eric Kelsic, CEO of Dyno Therapeutics, is doing! Listen to the full episode here: signal.nucleate.xyz/revolutionizin… #GeneTherapy #AI #Biotech #Innovation #MachineLearning #AAV

🚀 Kicking off Nucleate Germany’s Activator 2025! 🛡️⚖️ This week, we gathered at Vossius & Partner in Munich for an inspiring start teams met, collaborated, and dove into their first workshop on IP strategy. More updates & the Activator 2025 teams announcement coming soon! 👥